BillionaireClubCollc
  • News
  • Notifications
  • Shop
  • Cart
  • Media
  • Advertise with Us
  • Profile
  • Groups
  • Games
  • My Story
  • Chat
  • Contact Us
home shop notifications more
Signin
  •  Profile
  •  Sign Out
Skip to content

Billionaire Club Co LLC

Believe It and You Will Achieve It

Primary Menu
  • Home
  • Politics
  • TSR
  • Anime
  • Michael Jordan vs.Lebron James
  • Crypto
  • Soccer
  • Dating
  • Airplanes
  • Forex
  • Tax
  • New Movies Coming Soon
  • Games
  • CRYPTO INSURANCE
  • Sport
  • MEMES
  • K-POP
  • AI
  • The Bahamas
  • Digital NoMad
  • Joke of the Day
  • RapVerse
  • Stocks
  • SPORTS BETTING
  • Glamour
  • Beauty
  • Travel
  • Celebrity Net Worth
  • TMZ
  • Lotto
  • COVD-19
  • Fitness
  • The Bible is REAL
  • OutDoor Activity
  • Lifestyle
  • Culture
  • Boxing
  • Food
  • LGBTQ
  • Poetry
  • Music
  • Misc
  • Open Source
  • NASA
  • Science
  • Natural & Holstict Med
  • Gardening
  • DYI
  • History
  • Art
  • Education
  • Pets
  • Aliens
  • Astrology
  • Farming and LiveStock
  • LAW
  • Fast & Furious
  • Fishing & Hunting
  • Health
  • Credit Repair
  • Grants
  • All things legal
  • Reality TV
  • Africa Today
  • China Today
  • "DUMB SHIT.."
  • Stocks

Humana Stock Is at Multiyear Lows as Investors Digest Its Medicare Rating

Bloomberg / Contributor/ Getty Images

Key TakeawaysJefferies downgraded Humana, warning how the latest Medicare ratings will affect results.The analysts noted that data from federal regulators showed Humana had a huge dropoff in Medicare customers. Humana is appealing CMS's decision, claiming the rating process is flawed.Shares of Humana have tumbled this year on concerns about medical costs and government regulations.
Humana (HUM) shares slid after Jefferies downgraded the insurer's stock, pointing to the negative impacts of the company's latest ratings for its Medicare offerings.Humana stock plunged last week after the Centers for Medicare & Medicaid Services (CMS) said the quality rating of one of its plans, which accounts for nearly half of its Medicare Advantage (MA) memberships, fell to 3.5 stars down from 4.5 stars last year. Higher star ratings generate bonus payments for the insurers that offer plans that earn them.Today the shares, down nearly 2%, are trading at lows not seen since the early days of the 2020 COVID-19 outbreak. Jefferies, meanwhile, cut its rating on Humana to “hold” from “buy,” and slashed its price target from $419 to $253, well off Wall Street's consensus around $327 according to Visible Alpha data.The analysts said that although Humana is suing the CMS, calling its star ratings process flawed—and noting that United Health Group (UNH) and Elevance Health (ELV) both filed successful appeals last year—they are continuing to move forward as if Humana would not win its appeal against CMS.Shares of Humana have sunk since the CMS rating came out last week, adding to a slump that began in January when the company first warned that higher medical costs and government regulations would hurt profits.

TradingView

Read the original article on Investopedia.

Welcome to Billionaire Club Co LLC, your gateway to a brand-new social media experience! Sign up today and dive into over 10,000 fresh daily articles and videos curated just for your enjoyment. Enjoy the ad free experience, unlimited content interactions, and get that coveted blue check verification—all for just $1 a month!

Source link

Share
What's your thought on the article, write a comment
0 Comments
×

Sign In to perform this Activity

Sign in
×

Account Frozen

Your account is frozen. You can still view content but cannot interact with it.

Please go to your settings to update your account status.

Open Profile Settings

Ads

  • Billionaire128 Liquid Gold Laptop Sleeve

    $ 28.00
  • Billionaire128 Liquid Gold Flag

    $ 25.00
  • Premium Billionaire128 Embroidered Champion Packable Jacket

    $ 52.00
  • News Social

    • Facebook
    • Twitter
    • Facebook
    • Twitter
    Copyright © 2024 Billionaire Club Co LLC. All rights reserved